-+ 0.00%
-+ 0.00%
-+ 0.00%

NKGEN BIOTECH REPORTS LONG-TERM CLINICAL OBSERVATIONS WITH INVESTIGATIONAL ALZHEIMER’S TREATMENT TROCULEUCEL AT CTAD 2026

Reuters·11/16/2026 18:07:11